Search Results

There are 32220 results for: content related to: Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the β cell

  1. You have free access to this content
    Immune-mediated β-cell death in type 1 diabetes: lessons from human β-cell lines

    European Journal of Clinical Investigation

    Volume 42, Issue 11, November 2012, Pages: 1244–1251, Yaíma L. Lightfoot, Jing Chen and Clayton E. Mathews

    Version of Record online : 25 AUG 2012, DOI: 10.1111/j.1365-2362.2012.02711.x

  2. Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 7, July 2013, Pages: 581–592, D. A. Schneider, A. M. Kretowicz and M. G. von Herrath

    Version of Record online : 21 JAN 2013, DOI: 10.1111/dom.12046

  3. You have free access to this content
    A distinct immunogenic region of glutamic acid decarboxylase 65 is naturally processed and presented by human islet cells to cytotoxic CD8 T cells

    Clinical & Experimental Immunology

    Volume 179, Issue 1, January 2015, Pages: 100–107, R. R. Knight, G. Dolton, D. Kronenberg-Versteeg, M. Eichmann, M. Zhao, G. C. Huang, K. Beck, D. K. Cole, A. K. Sewell, A. Skowera and M. Peakman

    Version of Record online : 26 NOV 2014, DOI: 10.1111/cei.12436

  4. The β Cell Population in Type 1 Diabetes

    Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium 292

    Daniel Pipeleers, Peter In 't Veld, Miriam Pipeleers-Marichal, Frans Gorus, Pages: 19–31, 2008

    Published Online : 12 AUG 2008, DOI: 10.1002/9780470697405.ch3

  5. Immunological pathways to β-cell damage in Type 1 diabetes

    Diabetic Medicine

    Volume 30, Issue 2, February 2013, Pages: 147–154, M. Peakman

    Version of Record online : 21 JAN 2013, DOI: 10.1111/dme.12085

  6. Pancreatic Pathology in Type 1 Diabetes in Human

    Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium 292

    Gregory Bock, Jamie Goode, Pages: 2–18, 2008

    Published Online : 12 AUG 2008, DOI: 10.1002/9780470697405.ch2

  7. Cytotoxic T Cell Mechanisms of β Cell Destruction in Non-Obese Diabetic Mice

    Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium 292

    Thomas W. H. Kay, Nadine L. Dudek, Kate Graham, Eugene Estella, Eveline Angstetra, Mark D. McKenzie, Jan Allison, Helen E. Thomas, Pages: 68–84, 2008

    Published Online : 12 AUG 2008, DOI: 10.1002/9780470697405.ch6

  8. You have free access to this content
    Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes

    Clinical & Experimental Immunology

    Volume 172, Issue 3, June 2013, Pages: 375–382, S. M. Cabrera, S. C. Colvin, S. A. Tersey, B. Maier, J. L. Nadler and R. G. Mirmira

    Version of Record online : 18 APR 2013, DOI: 10.1111/cei.12068

  9. You have free access to this content
    Progress in immune-based therapies for type 1 diabetes

    Clinical & Experimental Immunology

    Volume 172, Issue 2, May 2013, Pages: 186–202, M. von Herrath, M. Peakman and B. Roep

    Version of Record online : 10 APR 2013, DOI: 10.1111/cei.12085

  10. You have free access to this content
    Islet inflammation in human type 1 diabetes mellitus

    IUBMB Life

    Volume 66, Issue 11, November 2014, Pages: 723–734, Noel G. Morgan, Pia Leete, Alan K. Foulis and Sarah J. Richardson

    Version of Record online : 11 DEC 2014, DOI: 10.1002/iub.1330

  11. You have free access to this content
    Islet inflammation and CXCL10 in recent-onset type 1 diabetes

    Clinical & Experimental Immunology

    Volume 159, Issue 3, March 2010, Pages: 338–343, B. O. Roep, F. S. Kleijwegt, A. G. S. Van Halteren, V. Bonato, U. Boggi, F. Vendrame, P. Marchetti and F. Dotta

    Version of Record online : 5 JAN 2010, DOI: 10.1111/j.1365-2249.2009.04087.x

  12. You have free access to this content
    Immune intervention for type 1 diabetes mellitus

    International Journal of Clinical Practice

    Volume 65, Issue s170, February 2011, Pages: 61–70, J. S. Skyler

    Version of Record online : 16 FEB 2011, DOI: 10.1111/j.1742-1241.2010.02580.x

  13. Inverse vaccination with islet autoantigens to halt progression of autoimmune diabetes

    Drug Development Research

    Volume 72, Issue 8, December 2011, Pages: 788–804, Simon A. Hinke

    Version of Record online : 13 DEC 2011, DOI: 10.1002/ddr.20488

  14. A comprehensive guide to antibody and T-cell responses in type 1 diabetes

    Tissue Antigens

    Volume 62, Issue 5, November 2003, Pages: 359–377, S.M. Lieberman and T.P. DiLorenzo

    Version of Record online : 13 OCT 2003, DOI: 10.1034/j.1399-0039.2003.00152.x

  15. You have free access to this content
    Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus

    Clinical & Experimental Immunology

    Volume 171, Issue 2, February 2013, Pages: 135–146, A. E. Barcala Tabarrozzi, C. N. Castro, R. A. Dewey, M. C. Sogayar, L. Labriola and M. J. Perone

    Version of Record online : 3 JAN 2013, DOI: 10.1111/cei.12019

  16. You have free access to this content
    Reducing or increasing β-cell apoptosis without inflammation does not affect diabetes initiation in neonatal NOD mice

    European Journal of Immunology

    Volume 41, Issue 8, August 2011, Pages: 2238–2247, Emma M. Carrington, Cameron Kos, Yifan Zhan, Balasubramanian Krishnamurthy and Janette Allison

    Version of Record online : 4 JUL 2011, DOI: 10.1002/eji.201141476

  17. Type 1 Diabetes

    Textbook of Diabetes, Fourth Edition

    Ahmed J. Delli, Helena Elding Larsson, Sten-A. Ivarsson, A˚ke Lernmark, Alice P. S. Kong, Juliana C. N. Chan, Pages: 139–159, 2010

    Published Online : 9 JUL 2010, DOI: 10.1002/9781444324808.ch9

  18. You have free access to this content
    Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice

    Clinical & Experimental Immunology

    Volume 179, Issue 3, March 2015, Pages: 398–413, J. Babad, G. Mukherjee, A. Follenzi, R. Ali, B. O. Roep, L. D. Shultz, P. Santamaria, O. O. Yang, H. Goldstein, D. L. Greiner and T. P. DiLorenzo

    Version of Record online : 16 FEB 2015, DOI: 10.1111/cei.12465

  19. You have free access to this content
    Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes

    Clinical & Experimental Immunology

    Volume 177, Issue 1, July 2014, Pages: 149–160, C. N. Castro, A. E. Barcala Tabarrozzi, J. Winnewisser, M. L. Gimeno, M. Antunica Noguerol, A. C. Liberman, D. A. Paz, R. A. Dewey and M. J. Perone

    Version of Record online : 9 JUN 2014, DOI: 10.1111/cei.12322

  20. You have full text access to this OnlineOpen article
    Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes

    Clinical & Experimental Immunology

    Volume 177, Issue 3, September 2014, Pages: 571–585, W. S. Thompson, M. L. Pekalski, H. Z. Simons, D. J. Smyth, X. Castro-Dopico, H. Guo, C. Guy, D. B. Dunger, S. Arif, M. Peakman, C. Wallace, L. S. Wicker, J. A Todd and R. C. Ferreira

    Version of Record online : 24 JUL 2014, DOI: 10.1111/cei.12362